Arvee Laboratories (India) liquidity ratios

·UnclassifiedChart ›

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

15.20×	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
3.35×	3.35×	4.75×	3.11×	2.62×
2.13×	2.13×	3.76×	2.23×	2.12×
0.4	0.4	0.2	1.9	0.5
17.7	17.7	17.2	15.4	14.8

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ARVEE₹182.00

Arvee Laboratories (India) Limited

· Unclassified

₹ CrorePeersSPCENET GVPTECH MCL NITIRAJ ASPINWALLJMA SINTERCOMMcap ₹201 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Altman Z-Score (Other Equity as RE)	—	—	—	—	15.20
Current Ratio	2.62	3.11	4.75	3.35	3.35
Quick Ratio	2.12	2.23	3.76	2.13	2.13
Cash, Equiv & ST Investments	0.5	1.9	0.2	0.4	0.4
Working Capital	14.8	15.4	17.2	17.7	17.7

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.